What is BodyM?

Direct answer

BodyM is a GLP-1 progress tracker and community for people using medications such as semaglutide or tirzepatide. It helps users organize shots, dose weeks, weight trend, symptoms, body and face progress photos, nutrition signals, and AI weekly review in one private timeline.

Pattern read

The useful answer is not a single tip. It is the pattern behind the symptom, the dose week, and what changed before it appeared.

BodyM treats BodyM GLP-1 tracker as a tracking question first. A GLP-1 journey can look very different on a first dose week, a dose-increase week, a plateau week, or a week with lower food and fluid intake. The goal is to connect what you feel with the exact context around it instead of guessing from memory.

For this topic, the highest-value record is a short timeline: shot date, dose stage, symptom timing, meal tolerance, hydration, bowel rhythm, protein consistency, sleep, and whether the signal is improving or repeating. That record helps you decide whether this is a normal pattern to monitor, a habit to adjust, a community question to ask, or something to bring to your clinician with clear context.

Track next

Search answers should end in a record, not another vague article.

Medication name, dose, shot day, and dose-week stage

Weight trend, body photos, face photos, and visible progress notes

Nausea, constipation, reflux, fatigue, appetite, hydration, protein, sleep, and bowel rhythm

Questions and summaries to discuss with a clinician when symptoms or medication decisions matter

Safety boundary

BodyM does not diagnose, prescribe, dose, or replace clinician judgment. Severe symptoms, medication changes, or urgent concerns should be handled with a qualified clinician or emergency care.

Next best action

Use BodyM's two-minute GLP-1 body check to create a private baseline, then continue into weekly tracking.

Take the 2-minute body check Ask the community